期刊文献+

宫颈癌术前介入化疗栓塞的临床应用 被引量:3

The preoperative interventional chemoembolization for the treatment of cervical cancer: its clinical application
原文传递
导出
摘要 目的探讨Ⅰb~Ⅱb期宫颈癌术前介入化疗栓塞的临床疗效及病理学改变。方法对2005年1月至2009年1月在我院就诊的55例宫颈癌患者实施术前动脉介入化疗,抗癌药物为顺铂、表阿霉素、5-Fu,灌注化疗后用明胶海绵颗粒栓塞肿瘤供血动脉。结果55例宫颈癌患者经1~2次术前介入化疗后顺利手术切除,术后标本病理切片中可见大量坏死组织及淋巴细胞浸润,其中组织学完全缓解8例。结论宫颈癌术前介入化疗栓塞可有效缩小肿瘤体积,减少术中出血,部分患者可达到组织学完全缓解的效果。 Objective To assess the effectiveness of preoperative interventional chmoembolization in the treatment of cervical cancer and to observe the pathological changes of the tumor after the procedure.Methods During the period of Jan.2005-Jan.2009,preoperative interventional chemoembolization was performed in 55 patients with cervical cancer.The antineoplastic drugs included cisplatin,epirubicin and 5-Fu.In all patients,interventional arterial infusion chemotherapy was carried out before the embolization of bilateral tumor-feeding arteries with gelfoam was made.Results Fifty-five patients underwent radical resection surgery after receiving 1 or 2 times of chemoembolization.In postoperative pathological examination,massive necrosis and lymphocytic infiltration were found within the tumor and histological complete remisson(HCR) was seen in 8 patients.Conclusion For the treatment of cervical cancer,the preoperative interventional chemoembolization can effectively decrease the tumor size and reduce blood loss during operation,moreover,even HcR can be obtained in some patients.
作者 张帆 许哲
出处 《中国肿瘤临床与康复》 2010年第2期131-133,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 宫颈肿瘤 介入性化疗 病理评价 Cervical neoplasms Interventional chemotherapy Pathological evaluation
  • 相关文献

参考文献7

二级参考文献38

  • 1王平,彭芝兰,张家文,刘辉,张崇淑,曹泽毅.子宫颈癌新辅助化疗中不同化疗途径的疗效比较[J].中华妇产科杂志,2005,40(4):227-230. 被引量:108
  • 2岳天孚,杨秀玉.血管性介入技术在妇科肿瘤领域中的应用[J].中华妇产科杂志,1995,30(7):435-437. 被引量:23
  • 3葛宁灵.影响介入治疗中晚期肝癌疗效的病理因素分析[J].国外医学(肿瘤学分册),1996,23(3):173-175. 被引量:24
  • 4杨秀玉,杨宁,宋鸿钊,岳天孚.超选择性动脉插管持续灌注化疗治疗绒癌耐药患者的分析[J].中华妇产科杂志,1996,31(4):199-202. 被引量:41
  • 5Aoki Y,Tomita M,Sato T,etal.Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamouscell carcinoma of the cervix.Gynecol Oncol,2001,83:263-267.
  • 6Benedetti-Panici P,Greggi S,Colombo A,et al.Neoadjuvant chemotherapy and radicalsurgery versus exclusive radiotherapy in locally advanced squamous cell cervicalcancer:results from the Italian multicenter randomized study.J Clin Oncol,2002,20:179-188.
  • 7Hwang YY,Moon H,Cho SH,et al.Ten-year survival of patients with locally advanced,stageⅠb-Ⅱb cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.GynecolOncol,2001,82:88-93.
  • 8Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysisCollaboration.Neoadjuvant chemotherapy for locally advanced cervical cancer:a systematicreview and meta-analysis of individual patient data from 21 randomised trials.Eur JCancer,2003,39:2470-2486.
  • 9Tabata T,Takeshima N,Nishida H,et al.A randomized study of primarybleomycin,vincristine,mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapyversus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of thecervix.Anticancer Res,2003,23:2885-2890.
  • 10Duenas-Gonzalez A,Rivera L,Mota A,et al.The advantages of concurrent chemoradiationafter neoadjuvant chemotherapy for locally advanced cervical carcinoma.Arch MedRes,2002,33:201-202.

共引文献179

同被引文献17

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部